PUBLIC LAW 107-188-^JUNE 12, 2002 116 STAT. 615 "(4) PRIORITY COUNTERMEASURES. — For purposes of this section, the term 'priority countermeasure' means a drug, biologicgJ product, device, vaccine, vaccine adjuvant, antiviral, or diagnostic test that the Secretary determines to be— "(A) a priority to treat, identify, or prevent infection by a biological agent or toxin listed pursuant to section 351A(a)(l), or harm from any other agent that may cause a public health emergency; or "(B) a priority to diagnose conditions that may result in adverse health consequences or death and may be caused by the administering of a drug, biological product, device, vaccine, vaccine adjuvant, antiviral, or diagnostic test that is a priority under subpsu-agraph (A).". SEC. 126. EVALUATION OF NEW AND EMERGING TECHNOLOGIES 42 USC REGARDING BIOTERRORIST ATTACK AND OTHER PUBLIC 300hh-13. HEALTH EMERGENCIES. (a) IN GENERAL. —The Secret2iry of Health and Human Services (referred to in this section as the "Secretary") shall promptly carry out a program to periodically evaluate new and emerging technologies that, in the determination of the Secretary, are designed to improve or enhance the ability of public health or safety officials to conduct public health surveillance activities relating to a bioterrorist attack or other public health emergency. (b) CERTAIN ACTIVITIES. —In carrying out this subsection, the Secretary shall, to the extent practicable— (1) survey existing technology programs funded by the Federal Government for potentially useful technologies; (2) promptly issue a request, as necessary, for information from non-Federal public and private entities for ongoing activities in this area; and (3) evaluate technologies identified under paragraphs (1) and (2) pursuant to subsection (c). (c) CONSULTATION AND EVALUATION.— In carrying out subsection (b)(3), the Secretary shall consult with the working group under section 319F(a) of the Public HesJth Service Act, as well as other appropriate public, nonprofit, and private entities, to develop criteria for the evaluation of such technologies and to conduct such evaluations. (d) REPORT.— Not later than 180 days after the date of the Deadline, enactment of this Act, and periodically thereafter, the Secretary shall submit to the Committee on Energy and Commerce of the House of Representatives, and the Committee on HegJth, Education, Labor, and Pensions of the Senate, a report on the activities under this section. SEC. 127. POTASSIUM IODIDE. (a) IN GENERAL. —Through the national stockpile under section 121, the President, subject to subsections (b) and (c), shall make available to State and local governments potassium iodide tablets for stockpiling and for distribution as appropriate to public facilities, such as schools and hospitals, in quantities sufficient to provide adequate protection for the population within 20 miles of a nuclear power plant. (b) STATE AND LOCAL PLANS. — (1) IN GENERAL.—Subsection (a) applies with respect to a State or local government, subject to paragraph (2), if the government involved meets the following conditions: 42 USC 300hh-12 note. 99-194 0-03-21:QL3Partl
�
